Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Boehringer Ingelheim
Medtronic
Moodys
Dow

Last Updated: October 24, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021228

See Plans and Pricing

« Back to Dashboard

NDA 021228 describes DETROL LA, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from five suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the DETROL LA profile page.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 021228
Tradename:DETROL LA
Applicant:Pharmacia And Upjohn
Ingredient:tolterodine tartrate
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 021228
Medical Subject Heading (MeSH) Categories for 021228
Suppliers and Packaging for NDA: 021228
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-01 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01)
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-02 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-02)
Paragraph IV (Patent) Challenges for 021228
Tradename Dosage Ingredient NDA Submissiondate
DETROL LA CAPSULE, EXTENDED RELEASE;ORAL tolterodine tartrate 021228 2007-07-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength2MG
Approval Date:Dec 22, 2000TE:ABRLD:Yes
Patent:  Start TrialPatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:  Start TrialPatent Expiration:Feb 26, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:  Start TrialPatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021228

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000   Start Trial   Start Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000   Start Trial   Start Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000   Start Trial   Start Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKinsey
Baxter
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.